A smartphone app called MyGeneRank uses DNA data from genetic testing firm 23andMe to calculate an individual's genetic risk for coronary artery disease, say researchers at Scripps Research Institute. Of the 3,800 individuals enrolled to use the app, 721 provided complete information.
"We now have the opportunity to integrate a person's genetics into their cardiovascular health assessment to help them better understand their individualized risk and empower them to make the necessary modifications—including the addition of statin therapy—to their risk factor optimization plans," said Scripps' Dr. Evan Muse.
From Scripps Research Institute
View Full Article
Abstracts Copyright © 2022 SmithBucklin, Washington, DC, USA
No entries found